Clinical Trials Logo

Filter by:
NCT ID: NCT05576077 Recruiting - Breast Cancer Clinical Trials

A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

STARLING
Start date: January 17, 2023
Phase: Phase 1
Study type: Interventional

A multicenter trial to investigate TBio-4101, an autologous, neoantigen-selected, tumor-reactive TIL product, in patients with advanced solid malignancies.

NCT ID: NCT05576038 Recruiting - Celiac Disease Clinical Trials

Tryptophan for Impaired AhR Signaling in Celiac Disease

TIARSCeD
Start date: December 1, 2022
Phase: N/A
Study type: Interventional

This is a prospective, randomized, double-blind, placebo-controlled exploratory trial to evaluate the effect of L-tryptophan supplementation on celiac-related symptoms in individuals who have biopsy-confirmed celiac disease (CeD) and symptoms non-responsive to a gluten-free diet (GFD). Fifty participants, aged 18 to 75 years, who self-report persistent CeD-related symptoms despite taking a GFD for more than 1 year and who score > 40 on the Celiac Symptom Index (CSI) will be randomized to receive L-tryptophan or placebo for 3 weeks.

NCT ID: NCT05575492 Active, not recruiting - Cytomegalovirus Clinical Trials

A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

Start date: November 7, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The main purpose of study is to evaluate the safety and immunogenicity of different dose levels of mRNA-1647 versus control in healthy cytomegalovirus (CMV)-seronegative and CMV-seropositive female and male participants 9 to 15 years of age. In addition, mRNA-1647 will be evaluated in female participants 16 to 25 years as a comparator cohort.

NCT ID: NCT05575180 Completed - Clinical trials for High Altitude Effects

Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance

Start date: August 11, 2023
Phase: Phase 4
Study type: Interventional

A single-centered randomized doubled blinded placebo-controlled cross-over trial comparing two the effect of two carbonic anhydrase inhibitors on exercise performance in acute hypoxia. Participants will be young (under 40 years of age), healthy males and females who are regularly physically active.

NCT ID: NCT05575076 Enrolling by invitation - Alzheimer Disease Clinical Trials

Open-label Extension for Phase 3 Clinical Trials of Simufilam

Start date: November 7, 2022
Phase: Phase 3
Study type: Interventional

The goal of this open-label extension study is to assess long-term safety and tolerability of simufilam 100 mg in subjects who have completed the RETHINK-ALZ or REFOCUS-ALZ Phase 3 clinical trials.

NCT ID: NCT05575011 Recruiting - Healthy Volunteer Clinical Trials

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB115

Start date: October 10, 2022
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to evaluate the safety and tolerability of single ascending dose of BIIB115 administered via intrathecal (IT) bolus injection to healthy male participants in Part A and multiple ascending doses of BIIB115 administered via IT bolus injection to pediatric Spinal Muscular Atrophy (SMA) participants previously treated with onasemnogene abeparvovec in Part B. The secondary objective of the study is to evaluate the pharmacokinetics (PK) of single-dose of BIIB115 administered via IT bolus injection to healthy male participants in Part A and multiple ascending doses of BIIB115 administered via IT bolus injection to pediatric SMA participants who previously received onasemnogene abeparvovec in Part B.

NCT ID: NCT05574426 Completed - Healthy Clinical Trials

Efficacy of Movement Breaks in Real-World Settings

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of performing "exercise snacks" (short movement breaks throughout the day) on various measures of cardiometabolic health.

NCT ID: NCT05574413 Completed - Inflammation Clinical Trials

Impact of Acute Exercise Intensity and Pattern on Cytokine Function

AEX
Start date: September 15, 2022
Phase: N/A
Study type: Interventional

The immune system helps prevent illness, fights off infections, and repairs damaged tissues following an injury. However, when immune cells remain active for prolonged periods of time - a state known as "chronic inflammation" - they can contribute to the development and progression of chronic diseases like heart disease and diabetes. Exercise can reduce the risk of developing many of these diseases and at least part of the health benefits of exercise are due to the ability of exercise to reduce "chronic inflammation". The inflammation-lowering effects of exercise are typically captured by measuring hormone-like molecules released from immune cells called "cytokines" in the blood. In addition to changes in circulating cytokine levels, exercise may also alter how immune cells respond to these cytokines. How exercise intensity (i.e., how hard you are working during exercise) and pattern (i.e., exercising as a long continuous bout or in short intervals) impact the ability of immune cells to respond to cytokines is not well understood. A better understanding of how exercise intensity and pattern of exercise for reducing chronic inflammation may help determine the best types of exercises for improving health and preventing chronic diseases.

NCT ID: NCT05574192 Enrolling by invitation - Loneliness Clinical Trials

The Social Engagement Project: Addressing Isolation With Women Affected by Violence

SEP
Start date: October 17, 2022
Phase: N/A
Study type: Interventional

The goal of this study is to test a pilot intervention aimed at improving social connectedness among women affected by gender-based violence in a resource-restricted, urban context. The intervention will specifically address barriers to building and sustaining supportive social networks to reduce women's risks for worsening mental health associated with isolation, with a focus on barriers stemming from gender-based violence and poverty. The main question it aims to answer are: - How acceptable is the intervention to women affected by gender-based violence including the benefits, burdens and appropriateness in the context of their everyday lives? - How feasible is the intervention and study protocol? - What are the effects of a peer-led social engagement intervention to develop and sustain supportive social networks and reduce isolation among women affected by gender-based violence? Participants will engage in social activities with trained peer workers over a one-year period.

NCT ID: NCT05574153 Recruiting - Metabolic Syndrome Clinical Trials

Metabolic Risk Factors and Myocardial Oxygenation Reserve

(META-MORE)
Start date: June 30, 2021
Phase:
Study type: Observational

The purpose of this study is to use MRI images using the OS-CMR technique to view the differences in the hearts of healthy volunteers and participants with a condition called Metabolic Syndrome. The objectives of this project are to compare these two groups and to view how health risks, blood test results, and the time since a Metabolic diagnosis can affect heart health.